Indivisible Partners bought a new position in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 54,461 shares of the company’s stock, valued at approximately $820,000.
Several other hedge funds and other institutional investors have also recently bought and sold shares of BMEZ. Invesco Ltd. grew its holdings in BlackRock Health Sciences Term Trust by 42.7% during the third quarter. Invesco Ltd. now owns 929,121 shares of the company’s stock worth $13,398,000 after acquiring an additional 278,024 shares during the period. Wolverine Asset Management LLC grew its holdings in BlackRock Health Sciences Term Trust by 5,782.1% during the third quarter. Wolverine Asset Management LLC now owns 224,518 shares of the company’s stock worth $3,238,000 after acquiring an additional 220,701 shares during the period. Readystate Asset Management LP grew its holdings in BlackRock Health Sciences Term Trust by 664.6% during the third quarter. Readystate Asset Management LP now owns 247,074 shares of the company’s stock worth $3,563,000 after acquiring an additional 214,761 shares during the period. Shaker Financial Services LLC acquired a new position in shares of BlackRock Health Sciences Term Trust in the third quarter worth about $2,654,000. Finally, Penserra Capital Management LLC raised its position in shares of BlackRock Health Sciences Term Trust by 15.2% in the third quarter. Penserra Capital Management LLC now owns 1,332,633 shares of the company’s stock worth $19,216,000 after acquiring an additional 175,629 shares during the period.
BlackRock Health Sciences Term Trust Trading Up 0.9%
Shares of BlackRock Health Sciences Term Trust stock opened at $14.23 on Thursday. The firm has a 50-day simple moving average of $14.36 and a two-hundred day simple moving average of $14.86. BlackRock Health Sciences Term Trust has a fifty-two week low of $13.67 and a fifty-two week high of $15.80.
BlackRock Health Sciences Term Trust Dividend Announcement
BlackRock Health Sciences Term Trust Profile
BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.
The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.
Featured Stories
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.
